Betaine

Active ingredient: Betaine

In short: Betaine Anhydrous for Oral Solution is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations in pediatric and adult patients. Included within the category of homocystinuria are Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate

Forms & strengthsBetaine Anhydrous for Oral Solution is a white to off-white, crystalline, hygroscopic powder for oral solution available in bottles containing 180 grams of betaine anhydrous.
LabelCosette Pharmaceuticals, Inc.
Label updatedMay 21, 2026

What is Betaine used for?

Betaine Anhydrous for Oral Solution is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations in pediatric and adult patients. Included within the category of homocystinuria are

Cystathionine beta-synthase (CBS) deficiency

5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency

Cobalamin cofactor metabolism (cbl) defect

Betaine dosage

Therapy with Betaine Anhydrous for Oral Solution should be directed by physicians knowledgeable in the management of patients with homocystinuria.

Adults and Pediatric Patients 3 Years of Age and Older

The recommended dosage is 6 grams per day, administered orally in divided doses of 3 grams twice daily.

Pediatric Patients Less than 3 Years of Age

The recommended starting dosage is 100 mg/kg/day divided in twice daily doses, and then increased weekly by 50 mg/kg increments.

Monitoring

Monitor patient response to Betaine Anhydrous for Oral Solution by homocysteine plasma concentration. Increase the dosage in all patients gradually until the plasma total homocysteine concentration is undetectable or present only in small amounts. An initial response in homocysteine plasma concentrations usually occurs within several days and steady state plasma concentrations occur within a month.

Monitor plasma methionine concentrations in patients with CBS deficiency .

Maximum Dosage

Dosages of up to 20 grams/day have been necessary to control homocysteine concentrations in some patients. However, one pharmacokinetic and pharmacodynamic in vitro simulation study indicated minimal benefit from exceeding a twice-daily dosing schedule and a 150 mg/kg/day dosage for Betaine Anhydrous for Oral Solution.

Shake bottle lightly before removing cap.

Measure the number of scoops for the patient's dose with the scoop provided. One level scoop (1.9cc) is equivalent to 1 gram of betaine anhydrous powder.

Mix powder with 4 to 6 ounces (120 to 180 mL) of water, juice, milk, or formula until completely dissolved, or mix with food, then ingest mixture immediately.

Always replace the cap tightly after using and protect the bottle from moisture.

How to take Betaine — instructions & advice from the label

Preparation and Administration Instructions

Instruct patients and caregivers to administer Betaine Anhydrous for Oral Solution as follows:

Shake bottle lightly before removing cap.

Measure the number of scoops for the patient’s dose with the scoop provided. One level scoop (1.9cc) is equivalent to 1 gram of betaine anhydrous powder.

Mix powder with 4 to 6 ounces (120 to 180 mL) of water, juice, milk, or formula until completely dissolved, or mix with food, then ingest mixture immediately.

Always replace the cap tightly after using and protect bottle from moisture.

Distributed by:

Cosette Pharmaceuticals NC Laboratories, LLC

Lincolnton, NC 28092

Rev. 02/2026

8-0352CP2

Warnings & precautions

Do not take this medicine if: None.

Patients with homocystinuria due to cystathionine beta-synthase (CBS) deficiency may also have elevated plasma methionine concentrations. Treatment with Betaine Anhydrous for Oral Solution may further increase methionine concentrations due to the remethylation of homocysteine to methionine. Cerebral edema has been reported in patients with hypermethioninemia, including patients treated with Betaine Anhydrous for Oral Solution . Monitor plasma methionine concentrations in patients with CBS deficiency. Plasma methionine concentrations should be kept below 1,000 micromol/L through dietary modification and, if necessary, a reduction of Betaine Anhydrous for Oral Solution dosage.

Betaine side effects

The following serious adverse reactions are described elsewhere in labeling:

Hypermethioninemia and cerebral edema in patients with CBS deficiency .

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The assessment of clinical adverse reactions is based on a survey study of 41 physicians, who treated a total of 111 homocystinuria patients with Betaine Anhydrous for Oral Solution. Adverse reactions were retrospectively recalled and were not collected systematically in this open-label, uncontrolled, physician survey. Thus, this list may not encompass all types of potential adverse reactions, reliably estimate their frequency, or establish a causal relationship to drug exposure. The following adverse reactions were reported (Table 1):

Table 1: Number of Patients with Adverse Reactions to Betaine Anhydrous for Oral Solution by Physician Survey

Adverse Reactions | Number of Patients

Nausea | 2

Gastrointestinal distress | 2

Diarrhea | 1

"Bad Taste" | 1

"Caused Odor" | 1

Questionable psychological changes | 1

"Aspirated the powder" | 1

The following adverse reactions have been identified during post approval use of Betaine Anhydrous for Oral Solution. …

About this medicine

Betaine Anhydrous for Oral Solution is an agent for the treatment of homocystinuria. It contains no ingredients other than anhydrous betaine. Betaine Anhydrous for Oral Solution is a white to off-white, crystalline, hygroscopic powder, which is diluted in water and administered orally. The chemical name of betaine anhydrous powder is trimethylglycine. It has a molecular weight of 117.15. The structural formula is:

How it works: Betaine Anhydrous for Oral Solution acts as a methyl group donor in the remethylation of homocysteine to methionine in patients with homocystinuria. Betaine occurs naturally in the body. It is a metabolite of choline and is present in small amounts in foods such as beets, spinach, cereals, and seafood.

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 99b667fa-b00c-465b-bbed-36f317078115. Read the full official label on DailyMed.